Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains

This article was originally published in PharmAsia News

Executive Summary

FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain

You may also be interested in...

What’s In A PDUFA Reauthorization? Maybe These Issues…

FDA Will Have Risk-Based Import Screening System Up And Running Throughout U.S. By Year's End

Limited roll out of the PREDICT system shows it has been effective in identifying the riskier imports that should be the focus of inspectors' attention, Commissioner Hamburg tells House panel

FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan

Agency wants to target supply-chain threats and help judge the value of information received from third-party inspections.

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts